Department of Pharmacy Practice, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, Karnataka, India.
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5180-5182. doi: 10.26355/eurrev_202005_21215.
In a short span, Coronavirus disease (COVID-19) has become the world pandemic by rapidly spreading almost to all the countries around the globe, irrespective of the continent, population size, economic status and healthcare system. Despite the number of cases increasing exponentially in most of the countries, there exist certain disparities in terms of case-fatality rates. As of April 24, 2020, the case-fatality rate of COVID-19 is about 7.0%, with 193,671 deaths and 2,761,121 confirmed cases around the world. Although the United States of America (USA), Spain, Italy, France, and Germany are the top-most affected counties in terms of confirmed cases; France, Italy and Spain are leading the list in terms of case-fatality rates. Therefore, through this mini-review, authors sought to brief on possible assumptions (five D's) that might contribute to the varying case-fatality rates among different countries across the globe.
在短时间内，冠状病毒病（COVID-19）已迅速传播到全球几乎所有国家，无论其所在的大洲、人口规模、经济状况和医疗保健系统如何。尽管大多数国家的病例数量呈指数级增长，但病死率仍存在一定差异。截至 2020 年 4 月 24 日，COVID-19 的病死率约为 7.0%，全球确诊病例为 193671 例，死亡 2761121 例。尽管美国、西班牙、意大利、法国和德国是确诊病例最多的国家；但就病死率而言，法国、意大利和西班牙则位居前列。因此，通过本次小型综述，作者试图简要介绍可能导致全球不同国家病死率差异的五个假设（五个 D's）。
